Effect of the human endotoxin challenge on tedizolid tissue penetration
暂无分享,去创建一个
M. Zeitlinger | B. Jilma | C. Dorn | M. Bauer | P. Matzneller | C. Schoergenhofer | E. Lackner | M. Wölfl-Duchek | B. Wulkersdorfer | Anselm Jorda | V. Jalali
[1] M. Zeitlinger,et al. Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review , 2022, Clinical Pharmacokinetics.
[2] M. Zeitlinger,et al. Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial. , 2022, Journal of Antimicrobial Chemotherapy.
[3] M. Zeitlinger,et al. Determination of free clindamycin, flucloxacillin or tedizolid in plasma: Keep attention to physiological conditions when using ultrafiltration. , 2020, Biomedical chromatography : BMC.
[4] C. Kloft,et al. High voriconazole target‐site exposure after approved sequence dosing due to nonlinear pharmacokinetics assessed by long‐term microdialysis , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] D. Nicolau,et al. Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis , 2017, Antimicrobial Agents and Chemotherapy.
[6] D. Gilroy,et al. Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation , 2016, Journal of visualized experiments : JoVE.
[7] M. Zeitlinger,et al. Single- and Repeated-Dose Pharmacokinetics of Ceftaroline in Plasma and Soft Tissues of Healthy Volunteers for Two Different Dosing Regimens of Ceftaroline Fosamil , 2016, Antimicrobial Agents and Chemotherapy.
[8] R. Forsythe,et al. Assessment of foot perfusion in patients with a diabetic foot ulcer , 2016, Diabetes/metabolism research and reviews.
[9] Rodney L. Nyland,et al. Steady State Concentration , 2015 .
[10] A. Suffredini,et al. Human Endotoxin Administration as an Experimental Model in Drug Development , 2014, Clinical pharmacology and therapeutics.
[11] W. Jäger,et al. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections. , 2013, The Journal of antimicrobial chemotherapy.
[12] M. Grant,et al. Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers. , 2012, International journal of antimicrobial agents.
[13] H. Lehnert,et al. Metabolic Alterations in Adipose Tissue During the Early Phase of Experimental Endotoxemia in Humans , 2011, Hormone and Metabolic Research.
[14] R. Khalil,et al. Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.
[15] V D Schmith,et al. Effects of Inflammation on Pharmacokinetics/Pharmacodynamics: Increasing Recognition of Its Contribution to Variability in Response , 2008, Clinical pharmacology and therapeutics.
[16] M. Netea,et al. PLASMA OBTAINED DURING HUMAN ENDOTOXEMIA INCREASES ENDOTHELIAL ALBUMIN PERMEABILITY IN VITRO , 2006, Shock.
[17] Charlotte Kloft,et al. Microdialysis--theoretical background and recent implementation in applied life-sciences. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] Dongxu Liu,et al. C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. , 2005, Blood.
[19] J. G. van der Hoeven,et al. Microvascular permeability during experimental human endotoxemia: an open intervention study , 2005 .
[20] F. Legat,et al. Penetration of Fosfomycin into Inflammatory Lesions in Patients with Cellulitis or Diabetic Foot Syndrome , 2003, Antimicrobial Agents and Chemotherapy.
[21] R. Blouin,et al. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans , 1999, Clinical pharmacology and therapeutics.
[22] H. Eichler,et al. Penetration of Ciprofloxacin into the Interstitial Space of Inflamed Foot Lesions in Non-Insulin-Dependent Diabetes Mellitus Patients , 1999, Antimicrobial Agents and Chemotherapy.
[23] M. Hill,et al. Endotoxin interacts with tumor necrosis factor-alpha to induce vasodilation of isolated rat skeletal muscle arterioles. , 1996, Shock.
[24] C. Kloft,et al. Pilot Investigation on Long-Term Subcutaneous Microdialysis: Proof of Principle in Humans , 2012, The AAPS Journal.